"Attention of the Holders of Securities in Physical Mode is invited to Circular No. SEBI/HO/MIRSD/PoD-1/P/CIR/2023/181 dated November 17, 2023 issued by SEBI."

Products

WHAT WE DO

R & D Services

Pharmaids provides research R&D services in the area of chemistry and biology to support pharmaceuticals, biotech, nutraceuticals industries to ad in discovery and development of novel solutions.

 

Read More

Manufacturing Services
Services(CDMO Services)

Pharmaids has state of art facilities to take up projects in the areas of process chemistry Kilo scale manufacturing of NCE’s, Key Intermediates & APIs.

 

Read More